Clinical Trial Update: Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating repigmentation in diffuse vitiligo using apremilast in combination with phototherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Vitiligo | Phase 2 | Status: COMPLETED